Southeast Asset Advisors LLC Sells 7,935 Shares of Revvity, Inc. (NYSE:RVTY)

Southeast Asset Advisors LLC lessened its stake in Revvity, Inc. (NYSE:RVTY) by 41.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 11,413 shares of the company’s stock after selling 7,935 shares during the quarter. Southeast Asset Advisors LLC’s holdings in Revvity were worth $1,274,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Assetmark Inc. boosted its position in Revvity by 3,700.0% during the fourth quarter. Assetmark Inc. now owns 266 shares of the company’s stock worth $30,000 after purchasing an additional 259 shares during the period. Millstone Evans Group LLC purchased a new stake in shares of Revvity during the 4th quarter valued at approximately $38,000. Continuum Advisory LLC boosted its holdings in Revvity by 2,972.7% in the 3rd quarter. Continuum Advisory LLC now owns 338 shares of the company’s stock worth $43,000 after buying an additional 327 shares during the period. MassMutual Private Wealth & Trust FSB boosted its holdings in Revvity by 55.9% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company’s stock worth $43,000 after buying an additional 138 shares during the period. Finally, EverSource Wealth Advisors LLC grew its stake in Revvity by 33.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 522 shares of the company’s stock valued at $58,000 after buying an additional 131 shares in the last quarter. Institutional investors own 86.65% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. Sanford C. Bernstein lowered Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price target for the company. in a report on Friday, January 10th. Raymond James restated an “outperform” rating and issued a $145.00 target price (up previously from $140.00) on shares of Revvity in a research note on Monday, February 3rd. KeyCorp lifted their target price on Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. Bank of America raised shares of Revvity from a “neutral” rating to a “buy” rating and set a $138.00 price target on the stock in a report on Friday, December 13th. Finally, Barclays upped their target price on shares of Revvity from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Four research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $136.25.

Insider Buying and Selling

In other news, insider Tajinder S. Vohra sold 5,492 shares of Revvity stock in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total value of $641,520.52. Following the transaction, the insider now owns 19,652 shares in the company, valued at approximately $2,295,550.12. The trade was a 21.84 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Joel S. Goldberg sold 15,170 shares of the business’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $126.73, for a total value of $1,922,494.10. Following the completion of the sale, the insider now directly owns 33,400 shares of the company’s stock, valued at approximately $4,232,782. This trade represents a 31.23 % decrease in their position. The disclosure for this sale can be found here. 0.68% of the stock is currently owned by corporate insiders.

Revvity Price Performance

Shares of NYSE:RVTY opened at $94.79 on Monday. The company’s fifty day moving average price is $113.18 and its 200-day moving average price is $116.43. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. The firm has a market capitalization of $11.39 billion, a price-to-earnings ratio of 42.89, a PEG ratio of 3.82 and a beta of 1.07. Revvity, Inc. has a one year low of $93.54 and a one year high of $129.50.

Revvity (NYSE:RVTY) last released its earnings results on Friday, January 31st. The company reported $1.42 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same period in the previous year, the firm earned $1.25 EPS. On average, equities research analysts anticipate that Revvity, Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be issued a dividend of $0.07 per share. The ex-dividend date of this dividend is Thursday, April 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.30%. Revvity’s dividend payout ratio is 12.67%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.